|
Trust Performance (as of 10/29/2024) |
*Inception Date is 7/9/2024 |
|
Cumulative Total Return |
Average Annual Total Return |
|
YTD |
Since Inception* |
3 mo |
6 mo |
1 yr |
3 yr |
5 yr |
10 yr |
Since Inception* |
With Transactional Sales Charge |
N/A |
2.65% |
1.79% |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Without Transactional Sales Charge |
N/A |
4.06% |
3.18% |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
|
Distributions Received in Cash |
With Transactional Sales Charge |
N/A |
2.65% |
1.79% |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Without Transactional Sales Charge |
N/A |
4.06% |
3.18% |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
|
S&P 500 (SPX) |
N/A |
4.98% |
7.11% |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
|
|
Cumulative Total Return |
Average Annual Total Return |
With Transactional Sales Charge (Distributions Reinvested) |
2.65% |
|
N/A |
|
Without Transactional Sales Charge (Distributions Reinvested) |
4.06% |
|
N/A |
|
With Transactional Sales Charge (Distributions Received in Cash) |
2.65% |
|
N/A |
|
Without Transactional Sales Charge (Distributions Received in Cash) |
4.06% |
|
N/A |
|
S&P 500 (SPX) |
4.98% |
|
N/A |
|
|
Sales Charges (based on a $10 public offering price) |
Transactional Sales Charges: |
Initial: |
0.00% |
|
Deferred: |
1.35% |
Creation & Development Fee: |
|
0.50% |
Maximum Sales Charge: |
|
1.85% |
|
|
Creation & Development Fee: |
0.50% |
Maximum Sales Charge: |
0.50% |
|
The table above shows the initial offering period sales charge. Certain performance periods shown on this page may begin after the end of the initial offering period and reflect a secondary market sales charge. Please see the prospectus for sales charge details, including the secondary market sales charge amount applicable to a period. |
Past Performance is no indication of future results. Investment returns and principal value will fluctuate and units when sold or redeemed,
may be worth more or less than their original cost. All returns are historical and do not represent potential future performance. This report is not
and should not be construed as an offer to buy or sell securities.
Unless an index is indicated to be a price only index, all index returns assume that dividends are reinvested when they are received.
Returns With Transactional Sales Charge reflect the maximum transactional sales charge that would be payable by an investor upon sale or
redemption of units at the end of the applicable period(s). The transactional sales charge includes any initial or deferred sales charges other than the
creation and development fee. These returns do not reflect any creation and development fee prior to collection (generally the close of the initial offering period).
Any creation and development fee is reflected in the returns as of the time of payment by a trust.
Returns Without Transactional Sales Charge do not reflect any transactional sales charge and do not reflect any creation and development fee prior
to collection (generally the close of the initial offering period). Any creation and development fee is reflected in the returns as of the time of payment by a trust.
If applicable, returns shown with distributions reinvested assume distributions are reinvested on the reinvestment date.
Risk Considerations Equity Risk. An investment in a portfolio containing common stocks is subject to certain risks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market. Buy & Hold Risk – Taxable Trusts. This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity. There may be tax consequences unless units are purchased in an IRA or other qualified plan. COVID-19 Economic Impact Risk. The ongoing effects of the COVID-19 global pandemic, or the potential impacts of any future public health crisis, may cause significant volatility and uncertainty in global financial markets. While vaccines have been developed, there is no guarantee that vaccines will be effective against future variants of the disease. Emerging Markets Risk. Risks associated with investing in non-U.S. securities may be more pronounced in emerging and developing markets where the securities markets are substantially smaller, less developed, less liquid, less regulated, and more volatile than the U.S. and developed non-U.S. markets. Foreign Securities Risk. Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting non-U.S. issuers. Large-Cap Risk. Large capitalization companies may grow at a slower rate than the overall market. Market Disruption Risk. Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East, have caused and could continue to cause significant market disruptions and volatility within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance. REITs Risk. An investment in a portfolio containing REIT securities is subject to additional risks including limited diversification. Companies involved in the real estate industry are subject to changes in the real estate market, vacancy rates and competition, volatile interest rates and economic recession. Small-Cap and Mid-Cap Risk. An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information. Volatility Risk. The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers. Operational Risk. As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cybersecurity.
You should carefully consider the trust's investment objectives, risks, and charges and expenses before investing. Contact your financial professional or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the trust. Read it carefully before you invest.
This product information does not constitute an offer to sell, or a solicitation of an offer to buy securities in any state to any person to whom it is not lawful to make such an offer. Sales of any of these securities must include prospectus delivery and the services of a retail broker/dealer duly licensed in the appropriate states.
Not FDIC Insured, Not Bank Guaranteed and May Lose Value.
The Dow Jones Industrial Average is a product of S&P Dow Jones Indices LLC or its affiliates ("SPDJI") and has been licensed for use by First Trust Portfolios L.P. Standard & Poor's® and S&P® are registered trademarks of Standard & Poor's Financial Services LLC ("S&P"); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones"); and these trademarks have been licensed for use by SPDJI and sublicensed for certain purposes by First Trust Portfolios L.P. This product is not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the advisability of investing in such product nor do they have any liability for any errors, omissions, or interruptions of the Dow Jones Industrial Average. Source ICE Data Indices, LLC, is used with permission. "NYSE®" is a service/trade mark of ICE Data Indices, LLC or its affiliates and has been licensed, along with the NYSE® International 100 Index ("Index") for use by First Trust Portfolios L.P. Neither First Trust Portfolios L.P. nor the product, as applicable, is sponsored, endorsed, sold or promoted by ICE Data Indices, LLC, its affiliates or its Third Party Suppliers ("ICE Data and its Suppliers"). ICE Data and its Suppliers make no representations or warranties regarding the advisability of investing in securities generally, in the Product particularly, or the ability of the Index to track general market performance. Past performance of an Index is not an indicator of or a guarantee of future results.
ICE DATA AND ITS SUPPLIERS DISCLAIM ANY AND ALL WARRANTIES AND REPRESENTATIONS, EXPRESS AND/OR IMPLIED, INCLUDING ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, INCLUDING THE INDICES, INDEX DATA AND ANY INFORMATION INCLUDED IN, RELATED TO, OR DERIVED THEREFROM ("INDEX DATA"). ICE DATA AND ITS SUPPLIERS SHALL NOT BE SUBJECT TO ANY DAMAGES OR LIABILITY WITH RESPECT TO THE ADEQUACY, ACCURACY, TIMELINESS OR COMPLETENESS OF THE INDICES AND THE INDEX DATA, WHICH ARE PROVIDED ON AN "AS IS" BASIS AND YOUR USE IS AT YOUR OWN RISK. The S&P MidCap 400 and the S&P SmallCap 600 Indices are products of S&P Dow Jones Indices LLC or its affiliates ("SPDJI") and have been licensed for use by First Trust Portfolios L.P. Standard & Poor's® and S&P® are registered trademarks of Standard & Poor's Financial Services LLC ("S&P"); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones"); and these trademarks have been licensed for use by SPDJI and sublicensed for certain purposes by First Trust Portfolios L.P. This product is not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the advisability of investing in such product nor do they have any liability for any errors, omissions, or interruptions of the S&P MidCap 400 and the S&P SmallCap 600 Indices.
CUSIP identifiers have been provided by CUSIP Global Services, managed on behalf of the American Bankers Association by FactSet Research Systems Inc. and are not for use or dissemination in a manner that would serve as a substitute for any CUSIP service. The CUSIP Database, ©2024 CUSIP Global Services. "CUSIP" is a registered trademark of the American Bankers Association.
|
|
30336F686 |
(Cash) |
30336F694 |
(Reinvest) |
30336F702 |
(Cash-Fee) |
30336F710 |
(Reinvest-Fee) |
|
|
|